Remission and relapse of Crohn's disease following autologous haematopoietic stem cell transplantation for non-Hodgkin's lymphoma [8]

Gut

Volumn 56, Issue 9, 2007, Pages 1325-

  Anumakonda, V ^a   Hayee, B ^a   Chung Faye, G ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MESALAZINE;

ABDOMINAL PAIN; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOODY DIARRHEA; COMBINATION CHEMOTHERAPY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE FREE INTERVAL; ERYTHEMA NODOSUM; HUMAN; LETTER; MONOTHERAPY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; T LYMPHOCYTE;

ADULT; CROHN DISEASE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, NON-HODGKIN; RECURRENCE; REMISSION INDUCTION;

EID: 34548120891     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.111377     Document Type: Letter

References (5)

1. Oyoma Y, Craig R, Traynor AE, et al. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. Gastroenterology 2005;128:552-63.
2. Kandiel A, Fraser AG, Korelitz BI, et al. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut, 2005 Aug, 54:1121-5.
3. Hinterberger W, Hinterberger-Fischer M, Marmont AM. Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favourably affects outcomes after stem cell transplantation in human autoimmune disease. Bone Marrow Transplant 2002;30:753-9.
4. Lopez-Cubero SO, Sullivan KM, McDonald GB. Course of Crohn's disease after allogeneic marrow transplantation. Gastroenterology 1998;114:433-40.
5. Barkholt L, Löfberg R. Resetting the immune system in refractory Crohn's disease: is autologous hematopoietic stem cell transplantation the way forward? Gastroenterology 2005;128:786-9.